Profile cover photo
Profile photo
MetaStat Inc.
2 followers -
MetaStat, Inc. (OTCQB: MTST) develops and commercializes diagnostic tests for risk of cancer metastasis, companion diagnostics and anti-metastatic drugs.
MetaStat, Inc. (OTCQB: MTST) develops and commercializes diagnostic tests for risk of cancer metastasis, companion diagnostics and anti-metastatic drugs.

2 followers
About
Posts

Post has attachment
Metastat announces results from two clinical studies of its MetaSite Breast™ test reported at the 39th San Antonio Breast Cancer Symposium (SABCS) demonstrating that the MetaSite Score was significantly associated with increased risk of distant metastasis in Hormone Receptor (HR-positive), HER2-negative Early Stage Breast Cancer (ESBC). “We are pleased to present positive results from two prospectively designed, retrospective studies of MetaSite Breast™ confirming the clinical validity of the association between MetaSite Score and distant cancer metastasis,” said Douglas A. Hamilton, MetaStat’s President and CEO. Click to learn more.
Add a comment...

Post has attachment
Aggressive cancer that metastasizes or spreads from a primary tumor through the bloodstream to other areas of the body is responsible for approximately 90% of all solid tumor cancer related deaths. MetaStat's focus is on preventing aggressive tumors from spreading. Learn more on our website:
Add a comment...

Post has attachment
Over two-thirds of healthcare professionals surveyed reported improved patient outcomes from personalized medicine initiatives. Learn more from ZDNet.
Add a comment...

Post has attachment

Post has attachment
Learn more about genomic testing & precision medicine's role in the future of oncology in this recent Oncology Times article.
Add a comment...

Post has attachment
MetaStat is a pre-commercial biotechnology company focused on the development and commercialization of diagnostic tests that are prognostic for risk of cancer metastasis, companion diagnostics to predict drug response, and anti-metastatic drugs. Learn more on our website.
Add a comment...

Post has attachment
A new study indicates that advances in precision medicine, such as tests to help reduce overtreatment in breast cancer patients, have improved breast cancer treatment.
Add a comment...

Post has attachment
Boston hospitals join sweeping national effort to gather medical data as part of their participation in the national Precision Medicine Initiative.
Add a comment...

Post has attachment
Precision medicine has grown rapidly in the past several years in part due to advances in gene sequencing and molecular-level diagnoses. Click to learn more:
Add a comment...

Post has attachment
Wait while more posts are being loaded